-
1
-
-
35948996162
-
Prevalence of symptomatic androgen deficiency in men
-
Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007; 92: 4241-4247.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 4241-4247
-
-
Araujo, A.B.1
Esche, G.R.2
Kupelian, V.3
O'Donnell, A.B.4
Travison, T.G.5
Williams, R.E.6
-
2
-
-
80053940592
-
-
Census UBot 2010 Census UBot: Washington, DC
-
Census UBot. Age and sex composition: 2010Census UBot: Washington, DC, 2011.
-
(2011)
Age and Sex Composition
-
-
-
3
-
-
84872491481
-
-
Summary from the 2nd Annual Andropause Consensus Meeting Chevy Chase, MD
-
Society TE. The Endocrine Society. Summary from the 2nd Annual Andropause Consensus Meeting Chevy Chase, MD 2001.
-
(2001)
The Endocrine Society
-
-
Society, T.E.1
-
4
-
-
58149299559
-
The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction
-
Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009; 30: 10-22.
-
(2009)
J Androl
, vol.30
, pp. 10-22
-
-
Traish, A.M.1
Guay, A.2
Feeley, R.3
Saad, F.4
-
5
-
-
68149138117
-
The dark side of testosterone deficiency: III. Cardiovascular disease
-
Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009; 30: 477-494.
-
(2009)
J Androl
, vol.30
, pp. 477-494
-
-
Traish, A.M.1
Saad, F.2
Feeley, R.J.3
Guay, A.4
-
6
-
-
58149310816
-
The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance
-
Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009; 30: 23-32.
-
(2009)
J Androl
, vol.30
, pp. 23-32
-
-
Traish, A.M.1
Saad, F.2
Guay, A.3
-
7
-
-
84928580276
-
Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate
-
Huggins C, Hudges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-297.
-
(1941)
Cancer Res
, vol.1
, pp. 293-297
-
-
Huggins, C.1
Hudges, C.V.2
-
8
-
-
13844262629
-
Comparative effects of DHEA vs tes-tosterone, dihydrotestosterone, and estradiol on proliferation and gene expres-sion in human LNCaP prostate cancer cells
-
Arnold JT, Le H, McFann KK, Blackman MR. Comparative effects of DHEA vs tes-tosterone, dihydrotestosterone, and estradiol on proliferation and gene expres-sion in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab 2005; 288: E573-E584.
-
(2005)
Am J Physiol Endocrinol Metab
, vol.288
-
-
Arnold, J.T.1
Le McFann H, K.K.2
Blackman, M.R.3
-
9
-
-
12544256922
-
Testosterone replacement therapy after primary treatment for prostate cancer
-
Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol 2005; 173: 533-536.
-
(2005)
J Urol
, vol.173
, pp. 533-536
-
-
Agarwal, P.K.1
Oefelein, M.G.2
-
10
-
-
4143066958
-
Androgen replacement after curative radical prosta-tectomy for prostate cancer in hypogonadal men
-
Kaufman JM, Graydon RJ. Androgen replacement after curative radical prosta-tectomy for prostate cancer in hypogonadal men. J Urol 2004; 172: 920-922.
-
(2004)
J Urol
, vol.172
, pp. 920-922
-
-
Kaufman, J.M.1
Graydon, R.J.2
-
11
-
-
63849109998
-
Testosterone replacement therapy following radical prostatectomy
-
Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ et al. Testosterone replacement therapy following radical prostatectomy. J Sex Med 2009; 6: 1165-1170.
-
(2009)
J Sex Med
, vol.6
, pp. 1165-1170
-
-
Khera, M.1
Grober, E.D.2
Najari, B.3
Colen, J.S.4
Mohamed, O.5
Lamb, D.J.6
-
12
-
-
57649148622
-
Testosterone administration to men with tes-tosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: Preliminary observations
-
Morales A, Black AM, Emerson LE. Testosterone administration to men with tes-tosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations. BJU Int 2009; 103: 62-64.
-
(2009)
BJU Int
, vol.103
, pp. 62-64
-
-
Morales, A.1
Black, A.M.2
Emerson, L.E.3
-
13
-
-
33846688614
-
Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy
-
Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer 2007; 109: 536-541.
-
(2007)
Cancer
, vol.109
, pp. 536-541
-
-
Sarosdy, M.F.1
-
14
-
-
79955394539
-
Effect of Testosterone Administration to Men with Prostate Cancer Is Unpredictable: A word of caution and suggestions for a registry
-
Morales A. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry. BJU Int 2011; 107: 1369-1373.
-
(2011)
BJU Int
, vol.107
, pp. 1369-1373
-
-
Morales, A.1
-
15
-
-
33644905301
-
Inter-mittent androgen replacementfor intense hypogonadism symptoms in castrated patients
-
Ferreira U, Leitao VA, Denardi F, Matheus WE, Stopiglia RM, Netto Jr. NR. Inter-mittent androgen replacementfor intense hypogonadism symptoms in castrated patients. Prostate Cancer Prostatic Dis 2006; 9: 39-41.
-
(2006)
Prostate Cancer Prostatic Dis
, vol.9
, pp. 39-41
-
-
Ferreira, U.1
Leitao, V.A.2
Denardi, F.3
Matheus, W.E.4
Stopiglia, R.M.5
Netto Jr., N.R.6
-
16
-
-
79952698470
-
Testosterone therapy in men with untreated prostate cancer
-
Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila Jr. D, Khera M. Testosterone therapy in men with untreated prostate cancer. J Urol 2011; 185: 1256-1260.
-
J Urol
, vol.2011
, Issue.185
, pp. 1256-1260
-
-
Morgentaler, A.1
Lipshultz, L.I.2
Bennett, R.3
Sweeney, M.4
Avila Jr., D.5
Khera, M.6
-
17
-
-
77951738484
-
Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
-
Leibowitz RL, Dorff TB, Tucker S, Symanowski J, Vogelzang NJ. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms. BJU Int 2010; 105: 1397-1401.
-
(2010)
BJU Int
, vol.105
, pp. 1397-1401
-
-
Leibowitz, R.L.1
Dorff, T.B.2
Tucker, S.3
Symanowski, J.4
Vogelzang, N.J.5
-
18
-
-
79953305847
-
Is testosterone a friend or a foe of the prostate?
-
Jannini EA, Gravina GL, Morgentaler A, Morales A, Incrocci L, Hellstrom WJ. Is testosterone a friend or a foe of the prostate? J Sex Med 2011; 8: 946-955.
-
(2011)
J Sex Med
, vol.8
, pp. 946-955
-
-
Jannini, E.A.1
Gravina, G.L.2
Morgentaler, A.3
Morales, A.4
Incrocci, L.5
Hellstrom, W.J.6
-
19
-
-
84872487104
-
-
NCCN. Prostate Cancer 2012
-
NCCN. Prostate Cancer 2012. http://www.nccn.org.
-
-
-
-
20
-
-
0035873091
-
Hypo-gonadism following prostate-bed radiation therapy for prostate carcinoma
-
Daniell HW, Clark JC, Pereira SE, Niazi ZA, Ferguson DW, Dunn SR et al. Hypo-gonadism following prostate-bed radiation therapy for prostate carcinoma. Cancer 2001; 91: 1889-1895.
-
(2001)
Cancer
, vol.91
, pp. 1889-1895
-
-
Daniell, H.W.1
Clark, J.C.2
Pereira, S.E.3
Niazi, Z.A.4
Ferguson, D.W.5
Dunn, S.R.6
-
21
-
-
0036096199
-
What happens to testosterone after prostate radiation monotherapy and does it matter?
-
Pickles T, Graham P. What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol 2002; 167: 2448-2452.
-
(2002)
J Urol
, vol.167
, pp. 2448-2452
-
-
Pickles, T.1
Graham, P.2
-
22
-
-
0030776408
-
Serum testosterone levels after external beam radiation for clinically localized prostate cancer
-
Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 85-89.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.39
, pp. 85-89
-
-
Zagars, G.K.1
Pollack, A.2
-
23
-
-
0024345285
-
Effects of radiation therapy and chemotherapy on testicular function
-
discussion 172-157
-
Kinsella TJ. Effects of radiation therapy and chemotherapy on testicular function. Prog Clin Biol Res 1989; 302: 157-171(discussion 172-157).
-
(1989)
Prog Clin Biol Res
, vol.302
, pp. 157-171
-
-
Kinsella, T.J.1
-
24
-
-
0022575074
-
The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate
-
Grigsby PW, Perez CA. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate. J Urol 1986; 135: 726-727.
-
(1986)
J Urol
, vol.135
, pp. 726-727
-
-
Grigsby, P.W.1
Perez, C.A.2
-
25
-
-
83955162957
-
Serum testosterone kinetics after brachytherapy for clinically localized prostate cancer
-
Taira AV, Merrick GS, Galbreath RW, Butler WM, Lief JH, Allen ZA et al. Serum testosterone kinetics after brachytherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2012; 82: e33-e38.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
-
-
Taira, A.V.1
Merrick, G.S.2
Galbreath, R.W.3
Butler, W.M.4
Lief, J.H.5
Allen, Z.A.6
-
26
-
-
0020507128
-
Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin
-
Tomic R, Bergman B, Damber JE, Littbrand B, Lofroth PO. Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin. J Urol 1983; 130: 287-289.
-
(1983)
J Urol
, vol.130
, pp. 287-289
-
-
Tomic, R.1
Bergman, B.2
Damber, J.E.3
Littbrand, B.4
Lofroth, P.O.5
-
27
-
-
0032324294
-
Influence of radical prostatectomy on serum hormone levels
-
Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI et al. Influence of radical prostatectomy on serum hormone levels. J Urol 1998; 160: 449-453.
-
(1998)
J Urol
, vol.160
, pp. 449-453
-
-
Miller, L.R.1
Partin, A.W.2
Chan, D.W.3
Bruzek, D.J.4
Dobs, A.S.5
Epstein, J.I.6
-
28
-
-
0018975785
-
Total and SHBG-bound testosterone and 5 alpha-dihydrotesto-sterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma
-
Lukkarinen O. Total and SHBG-bound testosterone and 5 alpha-dihydrotesto-sterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma. Br J Urol 1980; 52: 377-380.
-
(1980)
Br J Urol
, vol.52
, pp. 377-380
-
-
Lukkarinen, O.1
-
29
-
-
0019464367
-
Suppressive effects of surgical stress on circulating androgens during and after prostatectomy
-
Ghanadian R, Puah CM, Williams G, Shah PJ, McWhinney N. Suppressive effects of surgical stress on circulating androgens during and after prostatectomy. Br J Urol 1981; 53: 147-149.
-
(1981)
Br J Urol
, vol.53
, pp. 147-149
-
-
Ghanadian, R.1
Puah, C.M.2
Williams, G.3
Shah, P.J.4
McWhinney, N.5
-
30
-
-
84856530228
-
A Multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(R)) insertion
-
McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A Multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(R)) insertion. J Sex Med 2012; 9: 594-601.
-
(2012)
J Sex Med
, vol.9
, pp. 594-601
-
-
McCullough, A.R.1
Khera, M.2
Goldstein, I.3
Hellstrom, W.J.4
Morgentaler, A.5
Levine, L.A.6
-
31
-
-
0034872990
-
Pretreat-ment nomogram for predicting freedom from recurrence after permanent pros-tate brachytherapy in prostate cancer
-
Kattan MW, Potters L, Blasko JC, Beyer DC, Fearn P, Cavanagh W et al. Pretreat-ment nomogram for predicting freedom from recurrence after permanent pros-tate brachytherapy in prostate cancer. Urology 2001; 58: 393-399.
-
(2001)
Urology
, vol.58
, pp. 393-399
-
-
Kattan, M.W.1
Potters, L.2
Blasko, J.C.3
Beyer, D.C.4
Fearn, P.5
Cavanagh, W.6
-
32
-
-
0033526343
-
Radiation therapy for clinically ocalized prostate cancer: A multi-institutional pooled analysis
-
Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA et al. Radiation therapy for clinically ocalized prostate cancer: a multi-institutional pooled analysis. JAMA 1999; 281: 1598-1604.
-
(1999)
JAMA
, vol.281
, pp. 1598-1604
-
-
Shipley, W.U.1
Thames, H.D.2
Sandler, H.M.3
Hanks, G.E.4
Zietman, A.L.5
Perez, C.A.6
-
33
-
-
0041564148
-
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy
-
Pollack A, Hanlon AL, Movsas B, Hanks GE, Uzzo R, Horwitz EM. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 19-23.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 19-23
-
-
Pollack, A.1
Hanlon, A.L.2
Movsas, B.3
Hanks, G.E.4
Uzzo, R.5
Horwitz, E.M.6
-
34
-
-
0026322130
-
The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer
-
Holzman M, Carlton Jr. CE, Scardino PT. The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol 1991; 146: 1578-1582.
-
(1991)
J Urol
, vol.146
, pp. 1578-1582
-
-
Holzman, M.1
Carlton Jr., C.E.2
Scardino, P.T.3
-
35
-
-
57649176913
-
Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth
-
Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009; 55: 310-320.
-
(2009)
Eur Urol
, vol.55
, pp. 310-320
-
-
Morgentaler, A.1
Traish, A.M.2
-
36
-
-
13744261444
-
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis
-
Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA et al. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. J Urol 2005; 173: 797-802.
-
(2005)
J Urol
, vol.173
, pp. 797-802
-
-
Horwitz, E.M.1
Thames, H.D.2
Kuban, D.A.3
Levy, L.B.4
Kupelian, P.A.5
Martinez, A.A.6
-
37
-
-
83955165856
-
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial
-
Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011; 378: 2104-2111.
-
(2011)
Lancet
, vol.378
, pp. 2104-2111
-
-
Warde, P.1
Mason, M.2
Ding, K.3
Kirkbride, P.4
Brundage, M.5
Cowan, R.6
-
38
-
-
77957779215
-
Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis
-
Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010; 95: 4743-4747.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 4743-4747
-
-
Bachman, E.1
Feng, R.2
Travison, T.3
Li, M.4
Olbina, G.5
Ostland, V.6
-
39
-
-
0033304555
-
Pharmaco-kinetics efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men
-
Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmaco-kinetics efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84: 3469-3478.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 3469-3478
-
-
Dobs, A.S.1
Meikle, A.W.2
Arver, S.3
Sanders, S.W.4
Caramelli, K.E.5
Mazer, N.A.6
-
40
-
-
79953313802
-
A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treat-ment of male hypogonadism
-
Kaminetsky JC, Moclair B, Hemani M, Sand M. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treat-ment of male hypogonadism. J Sex Med 2011; 8: 1186-1196.
-
(2011)
J Sex Med
, vol.8
, pp. 1186-1196
-
-
Kaminetsky, J.C.1
Moclair, B.2
Hemani, M.3
Sand, M.4
-
41
-
-
80255132665
-
Identifying differences between biochemical failure and cure: Incidence rates and predictors
-
Vicini FA, Shah C, Kestin L, Ghilezan M, Krauss D, Ye H et al. Identifying differences between biochemical failure and cure: incidence rates and predictors. Int J Radiat Oncol Biol Phys 2011; 81: e369-e375.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
-
-
Vicini, F.A.1
Shah, C.2
Kestin, L.3
Ghilezan, M.4
Krauss, D.5
Ye, H.6
|